XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Series C Convertible Preferred Stock
IPO, Equity Line and Third Party
Preferred Stock
Series C Convertible Preferred Stock
Common Stock
Common Stock
Series C Convertible Preferred Stock
Common Stock
IPO, Equity Line and Third Party
Additional Paid-in Capital
Additional Paid-in Capital
Series C Convertible Preferred Stock
Additional Paid-in Capital
IPO, Equity Line and Third Party
Accumulated Deficit
Non Employee
Non Employee
Additional Paid-in Capital
Beginning Balance, Shares at Apr. 30, 2023       380,871 101,332                
Beginning Balance at Apr. 30, 2023 $ 230,557     $ 381 $ 101     $ 60,987,273     $ (60,757,198)    
Sale of Common Stock, net of issuance costs, Shares             4,420            
Sale of Common Stock, net of issuance costs     $ 391,950       $ 5     $ 391,945      
Common stock issued for consulting services, Shares         1,087                
Common stock issued for consulting services 100,000       $ 1     99,999          
Stock issued upon conversion, Shares       (431)   20              
Stock issued upon conversion       $ (1)         $ 1        
Stock based compensation expense 124,646             124,646          
Net loss (1,366,855)                   (1,366,855)    
Ending Balance, Shares at Jul. 31, 2023       380,440 106,859                
Ending Balance at Jul. 31, 2023 (519,702)     $ 380 $ 107     61,603,864     (62,124,053)    
Beginning Balance, Shares at Apr. 30, 2024       380,440 676,598                
Beginning Balance at Apr. 30, 2024 $ 7,317,301     $ 380 $ 677     74,678,650     (67,362,406)    
Sale of Common Stock, net of issuance costs, Shares 229,818       229,818   135,357            
Sale of Common Stock, net of issuance costs     $ 603,746       $ 136     $ 603,610      
Common Stock issued resulting from Reverse Stock Split, Shares         94,461                
Common Stock issued resulting from Reverse Stock Split         $ 94     (94)          
Stock issued upon conversion, Shares 20 431     76,027                
Stock based compensation expense $ 54,554             54,554          
Warrants issued to nonemployees                       $ 10,046 $ 10,046
Net loss (2,051,689)                   (2,051,689)    
Ending Balance, Shares at Jul. 31, 2024       380,440 906,416                
Ending Balance at Jul. 31, 2024 $ 5,933,958     $ 380 $ 907     $ 75,346,766     $ (69,414,095)